Bank of America just raised its EUR/USD forecast
PARIS, FRANCE - Novacyt (EPA:ALNOV) S.A. (EURONEXT GROWTH:ALNOV; AIM:NCYT), a global molecular diagnostics company, has scheduled its Annual General Meeting (AGM) for Thursday, June 19, 2025. The meeting will take place at the Hilton Hotel near Charles de Gaulle Airport in France, with a start time of 1pm CEST/12pm BST. The AGM will include both ordinary and extraordinary resolutions.
In a statement released on Wednesday, May 28, 2025, the company urged its shareholders to cast their votes in advance of the AGM. Shareholders can submit their votes by downloading a proxy voting form from Novacyt’s investor relations website and returning it with proof of shareholding by June 15, 2025. Online voting is available through the Votaccess portal, accessible from May 28, 2025, until June 18, 2025, at 2pm BST/3pm CEST. Additionally, shareholders may vote online via their brokers or other authorized intermediaries.
To be eligible to participate in the AGM, shareholders must prove that their shares are registered by midnight, Paris time, on June 16, 2025, either in the company’s registered securities accounts or in bearer securities accounts held by an authorized intermediary.
The company clarified that shareholders who have already voted will not be permitted to vote a second time at the AGM, but they may attend the meeting. Following the AGM, a recording will be made available on Novacyt’s website.
Novacyt specializes in molecular diagnostics, with a portfolio that spans human health, animal health, and environmental sectors. The company is headquartered in France and maintains offices in the UK, Singapore, the US, and Canada, with a commercial presence in over 65 countries.
This news is based on a press release statement from Novacyt S.A. and does not include any additional analysis or opinion.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.